Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data
about
Varicella zoster vaccines and their implications for development of HSV vaccinesVaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project dataThe natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.Cost-effectiveness of vaccination against herpes zoster.Viral exanthems: an update.Genetic variation in the HLA region is associated with susceptibility to herpes zosterTwenty Years of Medically-Attended Pediatric Varicella and Herpes Zoster in Ontario, Canada: A Population-Based StudyZoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus.Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models.Nationwide distribution of varicella-zoster virus clades in China.Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.Herpes zoster vaccination.Silicone-acyclovir controlled release devices suppress primary herpes simplex virus-2 and varicella zoster virus infections in vitroPathogenesis and current approaches to control of varicella-zoster virus infections.Practical considerations in the pharmacological treatment of postherpetic neuralgia for the primary care provider.Disseminated herpes zoster ophthalmicus in an immunocompetent 8-year old boy.Varicella zoster: an update on current treatment options and future perspectives.Clinical and molecular aspects of the live attenuated Oka varicella vaccine.Serum C-Reactive Protein and Congestive Heart Failure as Significant Predictors of Herpes Zoster Vaccine Response in Elderly Nursing Home Residents.The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling.Differential Diagnosis of Diaper Dermatitis.Herpes zoster - typical and atypical presentations.Immunogenicity of Varicella Vaccine and Immunologic Predictors of Response in a Cohort of Elderly Nursing Home Residents.Impact of vaccination on the epidemiology of varicella.Vaccine against herpes zoster.Perspectives on vaccination in adults.Post-herpetic neuralgia - a review of current management and future directions.Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination.On the Suppression of Vaccination DissentThe impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study
P2860
Q28280820-FFB984A7-F670-49A8-B33B-3B6DAF30CAC0Q30701352-7A87C9D7-DC6E-4840-8870-5059A80F4AC7Q33703581-1217C522-16FC-4927-AEC6-E2AD9C5F34DFQ34291150-1A885B34-455E-4FAC-9C7F-20C21E262B85Q34405380-463621C0-2AA7-43E4-BE68-EBCCCC19D746Q35020397-4E1F994F-3602-4B74-ADFC-720F0AB67950Q35692355-4C6B3B04-8E71-42C7-AAEB-DC4AC4EFD239Q36024466-6797A668-80AA-457A-9DE3-862D1F2F8889Q36149754-54B02F92-8968-4180-9B04-AA3E76ED467BQ36157980-7D646F07-58D7-4DC7-800E-889250049088Q36252698-79557FC3-E1E0-4F44-824F-23102CA2BE18Q37011064-BC423AB3-776F-47AE-A4CC-0185B7D499E4Q37105722-3F68BB5B-F4C9-4756-9379-E88ACF8EA078Q37263293-73386F95-6F84-4E12-8988-69B96416E117Q37641765-75B600A2-68CD-4B15-AEBF-02EFBBADCB1DQ37694187-A464264B-B77A-480D-B859-A80282BC905AQ38167380-1F74A422-53C3-4DCF-A248-58A519D32C31Q38200971-78050C11-80C0-4AA7-AFAE-D98E7D3C022EQ38609819-4AB6410B-8B48-4665-B2D0-0FD5483A2A27Q38781301-57414B05-108F-4D93-904A-3DD8DA9BE3ACQ39249085-126B863E-649D-4ADF-953B-1887DF15F4BAQ40187065-43B86348-FCA5-4662-B313-E144811C3838Q40515774-89B0ABAC-E72D-42ED-A880-D0A699D4187BQ40936245-03995BE3-E28D-4015-9F2A-73B4D4FC74ABQ42776436-BB745A7D-B673-4B12-A655-052852DD53EDQ43497830-2FD17EE2-B81F-49EE-BC6B-23ADF12E3C36Q47242634-035223CF-A0AA-4CAB-AC0E-A075B5EF7A64Q51439781-3A527420-57F3-422A-8570-67484DA15BCEQ56535096-4C91D8D1-255D-4819-B35C-C7E855D90D5EQ57395637-18D1CE55-ADEE-4870-8A54-FC332D342351
P2860
Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Review of the United States un ...... tive Surveillance Project data
@ast
Review of the United States un ...... tive Surveillance Project data
@en
Review of the United States un ...... tive Surveillance Project data
@nl
type
label
Review of the United States un ...... tive Surveillance Project data
@ast
Review of the United States un ...... tive Surveillance Project data
@en
Review of the United States un ...... tive Surveillance Project data
@nl
prefLabel
Review of the United States un ...... tive Surveillance Project data
@ast
Review of the United States un ...... tive Surveillance Project data
@en
Review of the United States un ...... tive Surveillance Project data
@nl
P2860
P921
P3181
P1433
P1476
Review of the United States un ...... tive Surveillance Project data
@en
P2093
G.S. Goldman
P2860
P304
P3181
P356
10.1016/J.VACCINE.2012.05.050
P407
P5008
P577
2013-03-25T00:00:00Z